WILLIAM PEACOCK to Dabigatran
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Dabigatran.
Connection Strength
1.468
-
Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series. J Emerg Med. 2019 Dec; 57(6):e167-e173.
Score: 0.718
-
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Stroke. 2017 08; 48(8):2142-2149.
Score: 0.153
-
Safety of direct oral anticoagulants: insights from postmarketing studies. Am J Emerg Med. 2016 Nov; 34(11S):9-13.
Score: 0.145
-
Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies. Am J Med. 2016 Nov; 129(11S):S41-S46.
Score: 0.144
-
Target-specific Oral Anticoagulants in the Emergency Department. J Emerg Med. 2016 Feb; 50(2):246-57.
Score: 0.137
-
Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers. Hosp Pract (1995). 2014 Oct; 42(4):75-82.
Score: 0.126
-
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants. Am J Emerg Med. 2020 06; 38(6):1163-1170.
Score: 0.045